The study and its comparison
Twenty-three healthy Japanese participants entered a ten-week placebo-controlled study of astaxanthin 4 mg daily. Controlled UV responses were measured at baseline and after nine weeks of supplementation. [1]
The astaxanthin group showed a higher minimum dose producing redness and less moisture loss in irradiated skin. Some subjective skin ratings also improved. [1]
What the finding establishes
These laboratory endpoints do not provide an SPF rating or demonstrate skin-cancer prevention. The sample was small. FUJIFILM funded and sponsored the work, and the three authors were affiliated with the company. The findings do not justify reducing established sun protection. [1]
A hypothetical distinction
Imagine a redness threshold rises in a small experiment. It cannot be converted into a sunscreen protection factor.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |

Sources for this article
- The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People-A Randomized, Double-Blind, Placebo-Controlled Trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.